Integrative Migraine Pain Alleviation Through Chiropractic Therapy

NCT03177616 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2023-03-03

No results posted yet for this study

Summary

This pilot study evaluates the addition of chiropractic treatment to conventional neurological care in the treatment of migraine headaches in adult women. Half of the participants will receive 10 chiropractic treatments in addition to their usual care over a 14 week period, while the other half will continue their usual medical care alone, as prescribed by their physician during that time period.

Conditions

  • Migraine
  • Migraine Disorders
  • Migraine With Aura
  • Migraine Without Aura
  • Migraine, Classic

Interventions

OTHER

Chiropractic Treatment

The treatment plan will be customized to the patient's needs. The chiropractic interventions are summarized as follows: * posture correction/spinal stabilization exercises * soft tissue relaxation techniques * spinal manipulation (i.e. chiropractic adjustment)/mobilization * breathing and relaxing techniques * stretches, self-care * ergonomic modifications * bracing and supports

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER
  • Palmer Center for Chiropractic Research (PCCR)

    collaborator OTHER
  • Harvard University Faculty of Medicine

    lead OTHER

Principal Investigators

  • Peter Wayne, Ph.D. · Harvard Medical School (HMS and HSDM)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-07
Primary Completion
2019-07-12
Completion
2022-11-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03177616 on ClinicalTrials.gov